How OneLegacy’s XVIVO EVLP center could expand access to transplantable donor lungs
OneLegacy’s new Western U.S. EVLP hub brings XVIVO lung perfusion closer to donor recovery, with major implications for transplant access.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
United Therapeutics wins FDA approval for LungFX, but pivotal survival data may shape uptake
The LungFX approval gives United Therapeutics control of a centralized donor lung evaluation platform, although clinical warnings, logistics and economics will influence adoption.